Produkty 6890-65-9

CAS 6890-65-9 występuje w naszej ofercie pod nazwami: (3alpha,5alpha)-3,17-Dihydroxypregnan-20-one, >95% (HPLC), (3Alpha,5Alpha)-3,17-Dihydroxypregnan-20-one. Oferty producentów: TRC, Biosynth. Dostępne opakowania: 100mg, 10mg, 50mg, 5mg, 25mg.

(3alpha,5alpha)-3,17-Dihydroxypregnan-20-one, >95% (HPLC)
TRC
  • opakowanie: 100mg, 10mg, 50mg
  • Warianty: 3
Zobacz produkt
(3Alpha,5Alpha)-3,17-Dihydroxypregnan-20-one
Biosynth
  • opakowanie: 10mg, 5mg, 25mg, 50mg
  • Warianty: 4
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

1-[(3R,5S,8R,9S,10S,13S,14S,17R)-3,17-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone (CAS 6890-65-9) to związek chemiczny o wzorze sumarycznym C21H34O3 i masie molowej 334.5 g/mol. Nazwa systematyczna IUPAC: 1-[(3R,5S,8R,9S,10S,13S,14S,17R)-3,17-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone. InChIKey: LKQDFQLSEHWIRK-JRRMKBMNSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H34O3
Masa molowa334.5 g/mol
Nazwa IUPAC1-[(3R,5S,8R,9S,10S,13S,14S,17R)-3,17-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone
InChIKeyLKQDFQLSEHWIRK-JRRMKBMNSA-N
SMILESCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)O)C)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 3alpha,17-Dihydroxy-5alpha-pregnan-20-one, (3alpha,5alpha)-3,17-dihydroxypregnan-20-one, 17alpha-hydroxyallopregnanolone, 3alpha,17alpha-Dihydroxy-5alpha-pregnan-20-one, 5alpha-Pregnane-3alpha,17alpha-diol-20-one, (3?,5?)-3,17-Dihydroxypregnan-20-one, 17-OH allopregnanolone, Hydroxyprogesterone Impurity 24, 17alpha-hydroxy-alloprogesterone, 5alpha-Pregnan-3alpha,17-diol-20-one
Powiązane formy tego związku
1-[(3S,5S,8R,9S,10S,13S,14S,17R)-3,17-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone C21H34O3
Izomery (ten sam wzór sumaryczny)
methyl (5Z,8Z)-10-[3-[(Z)-oct-2-enyl]oxiran-2-yl]deca-5,8-dienoate C21H34O3
methyl 4-[3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trienyl]oxiran-2-yl]butanoate C21H34O3
methyl (6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoate C21H34O3
1-[(3R,5R,8R,9S,10S,13S,14S,16R,17R)-3,16-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H34O3
2-hydroxy-1-[(3S,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H34O3
2-hydroxy-1-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H34O3
1-[(3R,5S,8S,9S,10S,11S,13S,14S,17S)-3,11-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H34O3
1-[(3S,5S,6R,8R,9S,10R,13S,14S,17S)-3,6-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H34O3
1-[(3R,5S,6S,8R,9S,10R,13S,14S,17S)-3,6-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H34O3
1-[(3R,5S,8S,9S,10S,11R,13S,14S,17S)-3,11-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H34O3
1-[(3R,8R,9S,10S,13R,14S,16R,17R)-3,16-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H34O3